OpinionNowadays, we have observed that discoveries in medical sciences have rapidly accelerated and continue to expand. One of the reasons for these positive recent changes is due to the onset of translational research. The term translational research, which was recently incorporated in the dictionary of medical sciences, indicates the integration of the advancements in basic science with clinical trials, taking research from the "bench-to-bedside"1 . This perspective gives rise to a completely new approach to improving health care for people with chronic diseases. Following this line of thought, we currently know that this scientific convergence works very well in several fields 1 , but can still be considered rare among nephrologists and neurologists. Evaluating the field of nephrology, the chronic renal failure, a progressive loss of kidney function that results in permanent kidney failure, is a worldwide public health problem. Furthermore, individuals in this condition need dialysis or a transplanted kidney. Even more problematic than these aspects, renal failure is associated with an increased risk of cardiovascular disease and sudden death 2 . Now, looking through the prism of Neurology, we know that epilepsy is considered the most common serious neurological condition. Unfortunately, each year about one in a 1000 patients with chronic epilepsy will die suddenly, unexpectedly, and without explanation, even with post-mortem examination 3 . Among neurologists around the world, this phenomenon is called sudden unexplained death in epilepsy (SUDEP). In the actual scenario, epilepsy is associated with a two-to three-fold increase in mortality compared to the general population, and SUDEP is the most important direct epilepsy-related cause of death 3 . Thus, as these two chronic diseases are very common in the world and also a global public health problem, a new line of translational research would have great value in helping neurologists and nephrologists to investigate what would be the best strategy to be drawn if these two chronic diseases involve the same individual. From this perspective and mainly due lack of data in the world, our research group decided to investigate the possible relationship between seizure frequencies in patients with end-stage renal disease (ESRD) under regular dialysis program 4 . Briefly, from 189 ESRD patients, 7 had suffered some type of convulsive seizure during dialytic program 4 . At that time, we concluded that despite the occurrence of seizures is considered rare among ESRD individuals receiving dialysis, it should be apparent that a true convergence of clinical nephrology and neurology should always be part of this scenario 4 . The next step for the researchers of our Institute of Nephrology was to verify the possible association between epilepsy and hence SUDEP in these individuals 5 . Overall, we noted in all the cases evaluated (7 out of 209) that cardiovascular abnormalities and hence SUDEP is a rare event in ESRD people with epilepsy receiving dialysis 5 . Although the...